Chiranjib Chakraborty , Manojit Bhattacharya , Soumen Pal , Sang-Soo Lee
{"title":"From machine learning to deep learning: Advances of the recent data-driven paradigm shift in medicine and healthcare","authors":"Chiranjib Chakraborty , Manojit Bhattacharya , Soumen Pal , Sang-Soo Lee","doi":"10.1016/j.crbiot.2023.100164","DOIUrl":null,"url":null,"abstract":"<div><p>The medicine and healthcare sector has been evolving and advancing very fast. The advancement has been initiated and shaped by the applications of data-driven, robust, and efficient machine learning (ML) to deep learning (DL) technologies. ML in the medical sector is developing quickly, causing rapid progress, reshaping medicine, and improving clinician and patient experiences. ML technologies evolved into data-hungry DL approaches, which are more robust and efficient in dealing with medical data. This article reviews some critical data-driven aspects of machine intelligence in the medical field. In this direction, the article illustrated the recent progress of data-driven medical science using ML to DL in two categories: firstly, the recent development of data science in medicine with the use of ML to DL and, secondly, the chabot technologies in healthcare and medicine, particularly on ChatGPT. Here, we discuss the progress of ML, DL, and the transition requirements from ML to DL. To discuss the advancement in data science, we illustrate prospective studies of medical image data, newly evolved DL interpretation data from EMR or EHR, big data in personalized medicine, and dataset shifts in artificial intelligence (AI). Simultaneously, the article illustrated recently developed DL-enabled ChatGPT technology. Finally, we summarize the broad role of ML and DL in medicine and the significant challenges for implementing recent ML to DL technologies in healthcare. The overview of the data-driven paradigm shift in medicine using ML to DL technologies in the article will benefit researchers immensely.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262823000461/pdfft?md5=a6c0a6806a62c83853da613908730833&pid=1-s2.0-S2590262823000461-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590262823000461","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The medicine and healthcare sector has been evolving and advancing very fast. The advancement has been initiated and shaped by the applications of data-driven, robust, and efficient machine learning (ML) to deep learning (DL) technologies. ML in the medical sector is developing quickly, causing rapid progress, reshaping medicine, and improving clinician and patient experiences. ML technologies evolved into data-hungry DL approaches, which are more robust and efficient in dealing with medical data. This article reviews some critical data-driven aspects of machine intelligence in the medical field. In this direction, the article illustrated the recent progress of data-driven medical science using ML to DL in two categories: firstly, the recent development of data science in medicine with the use of ML to DL and, secondly, the chabot technologies in healthcare and medicine, particularly on ChatGPT. Here, we discuss the progress of ML, DL, and the transition requirements from ML to DL. To discuss the advancement in data science, we illustrate prospective studies of medical image data, newly evolved DL interpretation data from EMR or EHR, big data in personalized medicine, and dataset shifts in artificial intelligence (AI). Simultaneously, the article illustrated recently developed DL-enabled ChatGPT technology. Finally, we summarize the broad role of ML and DL in medicine and the significant challenges for implementing recent ML to DL technologies in healthcare. The overview of the data-driven paradigm shift in medicine using ML to DL technologies in the article will benefit researchers immensely.
医药和医疗保健行业一直在快速发展和发展。这一进步是由数据驱动的、强大的、高效的机器学习(ML)与深度学习(DL)技术的应用所发起和塑造的。ML在医疗领域发展迅速,带来了快速进步,重塑了医学,改善了临床医生和患者的体验。机器学习技术演变为数据饥渴型深度学习方法,在处理医疗数据方面更加健壮和高效。本文回顾了医疗领域机器智能的一些关键数据驱动方面。在这个方向上,文章从两方面说明了使用ML to DL的数据驱动医学科学的最新进展:首先,使用ML to DL的医学数据科学的最新发展,其次,医疗保健和医学中的chabot技术,特别是ChatGPT。在这里,我们讨论ML、DL的进展,以及从ML到DL的转换需求。为了讨论数据科学的进展,我们阐述了医学图像数据的前瞻性研究,来自电子病历或电子病历的新发展的深度学习解释数据,个性化医疗中的大数据以及人工智能(AI)中的数据集转换。同时,本文说明了最近开发的支持dl的ChatGPT技术。最后,我们总结了机器学习和深度学习在医学中的广泛作用,以及在医疗保健中实施最新机器学习到深度学习技术的重大挑战。文章中对医学中使用ML到DL技术的数据驱动范式转换的概述将使研究人员受益匪浅。
期刊介绍:
Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines.
Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.